Wells Fargo’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,526
| Closed | -$497K | – | 7684 |
|
|
2024
Q1 | $497K | Buy |
12,526
+3,290
| +36% | +$97.1K | ﹤0.01% | 3896 |
|
|
2023
Q4 | $176K | Buy |
9,236
+2,201
| +31% | +$30.6K | ﹤0.01% | 4535 |
|
|
2023
Q3 | $80.6K | Sell |
7,035
-5,646
| -45% | -$69.5K | ﹤0.01% | 4911 |
|
|
2023
Q2 | $130K | Buy |
12,681
+8,289
| +189% | +$74.7K | ﹤0.01% | 4861 |
|
|
2023
Q1 | $33.9K | Buy |
+4,392
| New | +$35K | ﹤0.01% | 5380 |
|
|
2022
Q4 | – | Sell |
-127
| Closed | -$1K | – | 7807 |
|
|
2022
Q3 | $1K | Sell |
127
-163
| -56% | -$1.34K | ﹤0.01% | 6512 |
|
|
2022
Q2 | $2K | Sell |
290
-5,413
| -95% | -$46.7K | ﹤0.01% | 6407 |
|
|
2022
Q1 | $51K | Sell |
5,703
-3,735
| -40% | -$32.3K | ﹤0.01% | 5649 |
|
|
2021
Q4 | $130K | Sell |
9,438
-45,440
| -83% | -$563K | ﹤0.01% | 5498 |
|
|
2021
Q3 | $585K | Buy |
54,878
+54,578
| +18,193% | +$503K | ﹤0.01% | 4576 |
|
|
2021
Q2 | $3K | Sell |
300
-66
| -18% | -$717 | ﹤0.01% | 6488 |
|
|
2021
Q1 | $4K | Buy |
366
+299
| +446% | +$3.73K | ﹤0.01% | 6556 |
|
|
2020
Q4 | $1K | Buy |
67
+4
| +6% | +$39 | ﹤0.01% | 6396 |
|
|
2020
Q3 | $1K | Buy |
63
+37
| +142% | +$338 | ﹤0.01% | 6250 |
|
|
2020
Q2 | $0 | Hold |
26
| – | – | ﹤0.01% | 6981 |
|
|
2020
Q1 | $0 | Buy |
+26
| New | +$81 | ﹤0.01% | 6976 |
|
|
2019
Q3 | – | Sell |
-400
| Closed | -$2K | – | 6808 |
|
|
2019
Q2 | $2K | Hold |
400
| – | – | ﹤0.01% | 6193 |
|
|
2019
Q1 | $3K | Buy |
+400
| New | +$2.49K | ﹤0.01% | 5829 |
|
|
2018
Q2 | – | Sell |
-10,993
| Closed | -$88K | – | 6638 |
|
|
2018
Q1 | $88K | Buy |
10,993
+424
| +4% | +$4.19K | ﹤0.01% | 5362 |
|
|
2017
Q4 | $118K | Buy |
+10,569
| New | +$115K | ﹤0.01% | 5237 |
|
|
2016
Q2 | – | Sell |
-90
| Closed | -$1K | – | 6386 |
|
|
2016
Q1 | $1K | Buy |
90
+85
| +1,700% | +$1.7K | ﹤0.01% | 6119 |
|
|
2015
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6471 |
|
|
2015
Q3 | $0 | Buy |
+5
| New | +$329 | ﹤0.01% | 6510 |
|
Wells Fargo's ALPN Position: Q2 2024 in Review
Wells Fargo sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 12,526 shares — an estimated $497K sold.
Wells Fargo first reported a position in ALPN in Q3 2015 and held it in 23 quarters. The position peaked at $585K in Q3 2021. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Wells Fargo reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 12,526 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $497K.
- Wells Fargo first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 23 quarters.
- Wells Fargo's Alpine Immune Sciences Inc position peaked at $585K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.